Tissues with high metabolic rates often use lipids, as well as glucose, for energy, conferring a survival advantage during feast and famine 1 . Current dogma suggests that high-energy-consuming photoreceptors depend on glucose 2, 3 .
Here we show that the retina also uses fatty acid b-oxidation for energy. Moreover, we identify a lipid sensor, free fatty acid receptor 1 (Ffar1), that curbs glucose uptake when fatty acids are available. Very-low-density lipoprotein receptor (Vldlr), which is present in photoreceptors 4 and is expressed in other tissues with a high metabolic rate, facilitates the uptake of triglyceride-derived fatty acid 5, 6 . In the retinas of Vldlr −/− mice with low fatty acid uptake 6 but high circulating lipid levels, we found that Ffar1 suppresses expression of the glucose transporter Glut1. Impaired glucose entry into photoreceptors results in a dual (lipid and glucose) fuel shortage and a reduction in the levels of the Krebs cycle intermediate a-ketoglutarate (a-KG). Low a-KG levels promotes stabilization of hypoxia-induced factor 1a (Hif1a) and secretion of vascular endothelial growth factor A (Vegfa) by starved Vldlr −/− photoreceptors, leading to neovascularization. The aberrant vessels in the Vldlr −/− retinas, which invade normally avascular photoreceptors, are reminiscent of the vascular defects in retinal angiomatous proliferation, a subset of neovascular age-related macular degeneration (AMD) 7 , which is associated with high vitreous VEGFA levels in humans. Dysregulated lipid and glucose photoreceptor energy metabolism may therefore be a driving force in macular telangiectasia, neovascular AMD and other retinal diseases.
Retinal angiomatous proliferation (RAP) is observed in macular telangiectasia (MacTel) 8 , as well as in 15-20% of cases of neovascular AMD 7 , the leading cause of blindness in older adults 9 . Photoreceptors, which are densest in the macula, are among the highest energyconsuming and mitochondria-rich cell types 2,10 , suggesting the hypothesis that insufficient energy production for the high-energy demands of photoreceptors contributes to macular neovascularization. VEGFA contributes to retinal neovascularization, but factors that initiate VEGFA secretion in macular disease remain mostly unknown. We hypothesized that disordered photoreceptor mitochondrial energy metabolism might drive aberrant angiogenesis in the normally avascular photoreceptors in an attempt to increase fuel supply, consistent with the observation that dyslipidemia and mitochondrial dysfunction (which are associated with aging) are important risk factors for neovascular AMD 9 .
Retinal neurons are thought to rely on glucose for fuel 2, 3 . Glucose is metabolized to pyruvate (by glycolysis) and either converted to lactate in the cytoplasm or oxidized to acetyl-coenzyme A (acetyl-CoA) in mitochondria before entering the Krebs cycle to produce ATP. In photoreceptors, the major glucose transporter is solute carrier family 2 (facilitated glucose transporter), member 1 (Slc2a1; also known as Glut1) 11, 12 . Clinically, SLC2A1 (hereafter referred to as GLUT1) deficiency causes infantile seizures and developmental delay 13 , highlighting the importance of glucose metabolism in the brain. However, GLUT1-deficient individuals have normal vision, suggesting the use of alternative retinal energy substrates, perhaps through lipid β-oxidation.
Lipid β-oxidation commonly occurs in the heart and skeletal muscle (tissues with high metabolic rates), where abundant amounts Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1 of VLDLR facilitate fatty acid uptake 14 . VLDLR binds chylomicrons and enables cleavage of long-chain fatty acids from triglycerides by lipoprotein lipase 6 . Vldlr is involved in the transcytosis of active lipoprotein lipase across endothelial cells 15 , enabling the delivery of free fatty acid to tissue. Vldlr contributes to lipid uptake and fatty acid β-oxidation in the heart 5 . Because lipid β-oxidation enzymes are expressed in the eye 16 , we hypothesized that fatty acid β-oxidation is used for energy in lipid-and Vldlr-rich photoreceptors. VLDLR deletion causes maculopathy in humans 17 , and Vldlr −/− mice develop RAP-like retinal vascular lesions ( Fig. 1a) 4 . Study of Vldlr −/− mice thus allows for the exploration of the hypotheses that lipids fuel photoreceptors and that fuel deficiency promotes neovessel formation.
We first tested whether there was a link between the number of RAP-like lesions and photoreceptor energy demand. Rod photoreceptors consume 3-4 times more energy in darkness than in light to maintain the 'dark current' , an electrochemical gradient required for photon-induced polarization 10 . Conversely, membrane turnover and visual cycle activity are decreased in darkness 10 . Dark-raised Vldlr −/− mice developed 1.5-fold more RAP-like vascular lesions than light and dark cycle-raised mice ( Fig. 1b) , suggesting that energy metabolism influences neovascular disease. Photoreceptors mature from the optic nerve outward toward the periphery, and energy consumption increases as photoreceptors mature 2, 18 . In retinas from postnatal day 16 (P16) Vldlr −/− mice, the more mature central retina had more RAP-like lesions than the peripheral retina ( Fig. 1b) , consistent with this model.
To determine whether loss of Vldlr specifically in photoreceptors is sufficient to drive pathological vessel formation, we knocked down expression of Vldlr in the photoreceptors of Vldlr +/− mice, which have normal circulating fatty acid levels and do not have a RAP-like phenotype 19 . To knock down Vldlr expression selectively in photoreceptors, we used an adeno-associated virus (AAV) 2-derived hRK construct, which contains a photoreceptor-specific human rhodopsin kinase gene (GRK1) promoter driving the expression of shRNA that targets Vldlr expression. Loss of Vldlr expression in photoreceptors led to the development of RAP-like lesions (Supplementary Fig. 1) .
Consistent with the concept that Vldlr −/− photoreceptors are energy deficient, they had swollen mitochondria, as assessed by three-dimensional (3D) scanning electron microscopy ( Fig. 1c and Supplementary Videos 1 and 2). Moreover, retinas from Vldlr −/− mice had reduced ATP stores ( Fig. 1d) , confirming an energy deficit.
To explore the mechanistic basis of the photoreceptor energy deficit, we examined the contribution of fatty acids and glucose to energy production in wild-type (WT) retinas ( Supplementary  Fig. 2a ). The long-chain fatty acid palmitate fueled mitochondrial β-oxidation in retinal explants, doubling the oxygen-consumption rate (OCR); moreover, treatment with etomoxir, which inhibits fatty acid transport into mitochondria, abrogated palmitate-induced mitochondrial respiration, confirming that fatty acid β-oxidation contributes to retinal energy metabolism ( Fig. 2a,b and Supplementary  Fig. 2a-c) . We also examined the contribution of glucose oxidation and found that retinal glucose could be oxidized by mitochondria as efficiently as a fatty acid ( Supplementary Fig. 2d-f ). However, as reported by Warburg, Cohen and Winkler 3, 20 , the vast majority of glucose (87%) was converted to lactate by glycolysis rather than being used for oxidative phosphorylation (Supplementary Fig. 2g ). Unlike retinas from WT mice, those from Vldlr −/− mice (i.e., with limited fatty acid uptake) did not increase mitochondrial respiration after exposure to palmitate ( Supplementary Fig. 2h ). Therefore, in addition to glucose, fatty acids contribute to retinal energy production, which may be deficient in retinas from Vldlr −/− mice.
Given the possible role of VLDLR in retinal lipid energy metabolism, we quantified retinal fatty acid uptake. Consistent with a previous report 21 , Vldlr was highly expressed in retinal photoreceptors ( Supplementary Fig. 3a) , and uptake of long-chain fatty acids was reduced in retinas from Vldlr −/− mice ( Supplementary  Fig. 3b,c) . Serum turbidity reflected higher circulating lipid levels in Vldlr −/− versus WT mice ( Supplementary Fig. 3b,c) . Plasma levels of triglycerides and medium-and long-chain fatty acids (particularly palmitate) were elevated in Vldlr −/− mice as compared to WT mice ( Fig. 2c and Supplementary Fig. 3d,e ). Notably, fatty acid β-oxidation of lipids to produce acetyl-CoA in mitochondria was suppressed in retinas from Vldlr −/− mice (Fig. 2d) , and total Figure 1 Retinal energy deficits are associated with vascular lesions in Vldlr −/− mice. (a) Representative (of n = 5 retinas) flat-mount 3D reconstruction of confocal microscopy images of retinas from a P12 (left and middle) and a P16 (right) Vldlr −/− mouse, focusing on blood vessels (stained red with Simplifonica B4 isolectin) in the photoreceptor layer. At P12, pathologic vessels in Vldlr −/− retinas originated from the deep vascular plexus (DVP) and breached the outer plexiform layer; at P16, the vessels extended toward photoreceptor outer segments (OS). Scale bars, 500 µm (left) and 100 µm (middle and right). (b) Left, representative flat-mount images of retinas, imaged by focusing on the photoreceptor layer, from P16 Vldlr −/− pups that were raised with a normal 12-h light and 12-h dark cycle (control) or in darkness (dark). Pathological RAP-like vessels were pseudo-colored in white for quantification; the boxed area is enlarged in the middle micrographs. The graph shows the number of vascular lesions in retinas from P16 Vldlr −/− pups that were raised in control conditions (Ctl; n = 28 retinas) or in darkness (n = 10 retinas). Scale bars, 1 mm (left) and 0.5 mm (middle and right). P = 0.0031. (c) Representative 3D-reconstructed scanning electron microscopy (SEM) images of retinas from P16 WT (left) and Vldlr −/− (middle) mice and quantification of photoreceptor mitochondrial volume (right) (n = 23 photoreceptors per group). Mitochondria within photoreceptors are pseudo-colored. Scale bars, 5 µm. (d) ATP levels in retinas from P16 Vldlr −/− (n = 6) and WT littermate control (n = 4) mice. P = 0.0026. In all graphs, results are presented as mean ± s.e.m. **P < 0.01, ***P < 0.001; by two-tailed Student's t-test. npg acylcarnitine levels, as well as free carnitine levels, were reduced ( Fig. 2e) . Low cytosolic fatty acid levels in the retinas from Vldlr −/− mice were associated with decreased peroxisome proliferator activated receptor alpha (Ppara) mRNA expression 22 , mainly in the photoreceptors ( Supplementary Fig. 4a,b) . PPARA is a key regulator of several steps of fatty acid β-oxidation 22 and regulates expression of carnitine palmitoyl transferase 1a (Cpt1a), an enzyme that mediates internalization of fatty acids into mitochondria ( Supplementary  Fig. 2a ). Consistent with the effects observed for Ppara expression, Cpt1a mRNA expression was lower in photoreceptors from Vldlr −/− mice than in those from WT mice ( Fig. 2f) . Retinas from Vldlr −/− mice that had been treated with the selective Ppara agonist WY16463, which is used to enhance fatty acid β-oxidation 23 , showed reduced numbers of RAP-like lesions (Supplementary Fig. 4c ). Treatment of photoreceptor cells (661W cells) with palmitate increased mitochondrial respiration by fatty acid β-oxidation, and this was further increased by addition of the Ppara agonist GW9578; this effect was dependent on fatty acid β-oxidation, because treatment with etomoxir abrogated the increase in mitochondrial respiration ( Supplementary  Fig. 5a-d ). Extracellular acidification rates, which reflect lactate production from glycolysis, were not affected by Ppara agonist treatment ( Supplementary Fig. 5e,f) . Our findings therefore suggest that fatty acids are an energy substrate in retina and cultured photoreceptors.
We initially anticipated that a compensatory upsurge in glucose uptake would occur to mitigate fatty acid deficiency in Vldlr −/− retinas. However, glucose uptake assessed using the radiolabeled glucose analogue [ 18 F]FDG, as visualized by positron-emitting tomography (PET) and measured by gamma counts, was reduced in retinas from Vldlr −/− mice as compared to those from WT mice ( Fig. 2g and Supplementary Video 3); Glut1 expression was also reduced ( Fig. 2h,i) , particularly in Vldlr −/− photoreceptors ( Fig. 2h) . Consistent with these results, carbohydrate metabolism was the most significantly regulated pathway observed in gene microarray data comparing WT to Vldlr −/− retinas (Supplementary Fig. 6a ). Decreased expression Butyryl and isobutyryl (C4)
Decenoyl (C10:1) Methylmalonyl and succinyl (C4-DC) Glutaryl (C5-DC) Adipoyl and methylglutaryl (C6-DC) npg of the gene encoding pyruvate kinase (Pkm), which is a critical enzyme in glycolysis, was observed in Vldlr −/− retinas in the microarray experiment and confirmed by qRT-PCR ( Supplementary Fig. 6b ). Expression of the Slc2a3 (Glut3) and Slc2a4 (Glut4) proteins was not affected (Supplementary Fig. 6c ). Hence, Vldlr −/− retinas display both lipid-and glucose-uptake defects, consistent with a generalized energy shortage. We posited that despite the lipid-uptake deficiency in Vldlr −/− retinas, the increased abundance of lipids in serum from Vldlr −/− mice might signal through lipid sensors to reduce glucose uptake, as a means to control fuel supply to the retina (Fig. 3a) . Of the known fatty acid-sensing G protein-coupled membrane receptors (GPCRs) we screened in WT retinas, Ffar1 was the most abundantly expressed, and its expression level was increased further in retinas from Vldlr −/− mice, particularly in photoreceptors (Fig. 3b,c) . Ffar1, first discovered in the pancreas 24 , governs glucose transport and insulin secretion in pancreatic islet beta cells 25, 26 . High expression of Ffar1 in the pancreas suppresses expression of Slc2a2 (Glut2), the main endocrine pancreas glucose transporter 27 . Ffar1 has also been localized in the brain, where its function is not well characterized 28, 29 . In WT and Vldlr −/− retinas, we found that treatment with a Ffar1 agonist (GW9508) suppressed expression of Glut1 (ref. 12 ) and retinal glucose uptake (Fig. 3d,e and  Supplementary Fig. 7a) . Notably, treatment of Vldlr −/− mice with GW9508 more than doubled the number of RAP-like lesions, as compared to those in untreated controls (Fig. 3f) . Ffar1 binds lipids that contain >6 carbon atoms 29 . Vldlr −/− mice treated with medium-chain triglycerides (MCT; 8-10 carbon atoms), which are Ffar1 agonists 29 , or with the Ffar1-selective agonist TAK-875 (ref. 30 ) had a further decrease in the level of retinal Glut1 expression and more RAP-like lesions, as compared to untreated controls (Supplementary Fig. 8 ).
Next we generated mice that were deficient in both Vldlr and Ffar1. Retinas from Vldlr −/− Ffar1 −/− mice had increased glucose uptake and increased Glut1 expression at the mRNA and protein levels, as compared to those from Vldlr −/− mice (Fig. 3g,h, Supplementary  Fig. 7b,c and Supplementary Video 3) . Vldlr −/− Ffar1 −/− mice also had fewer RAP-like lesions than Vldlr −/− mice (Fig. 3i) . In vitro, knockdown of Ffar1 or treatment with the mitogen-activated protein kinase (MAPK) kinase inhibitor PD98059 prevented the suppression of Glut1 expression by GW9508 treatment in 661W photoreceptor cells (Supplementary Fig. 7d-f ). Therefore, Ffar1 may act as nutrient sensor, coupling mitochondrial metabolism with the availability of circulating substrates.
We hypothesized that photoreceptors challenged by a deficiency of both glucose and lipid substrates would signal to increase vascular supply in an attempt to restore energy homeostasis (Fig. 4a) . Hypoxia has been assumed to be the main driver of angiogenesis, but inadequate nutrient availability to tissue might also control blood vessel growth. As compared to WT retinas, Vldlr −/− retinas had reduced levels of pyruvate (a metabolic intermediate that feeds into the Krebs cycle), acetylcarnitine (which provides an estimation of acetyl-CoA levels) and α-KG ( Fig. 4b-d) . Together with oxygen, α-KG is a necessary co-activator of prolyl-hydroxylase dehydrogenase (PHD), the enzyme that tags Hif1a for degradation by proline hydroxylation 31 . A decreased level of hydroxyproline was detected in Vldlr −/− retinas as compared to WT retinas (Fig. 4e) , consistent with reduced PHD activity. Indeed, the reduction in retinal glucose uptake in 661W photoreceptor cells that was induced by GW9508 treatment or by glucose starvation was associated with Hif1a stabilization (Supplementary  Fig. 9a-c) and Vegfa secretion (Supplementary Fig. 9d,e) . In vivo, Hif1a stabilization in Vldlr −/− photoreceptors (Fig. 4f,g) was associated with increased Vegfa production ( Fig. 4h,i) . Concurrent Ffar1 and Vldlr deficiency reversed this effect and decreased Hif1a and Vegfa levels (Fig. 4f,h) , which was associated with fewer vascular lesions (Fig. 3i) .
Increased expression of Vegfa from photoreceptors is sufficient to promote RAP-like lesions. Mice engineered to secrete Vegfa in photoreceptors develop RAP comparable to that in Vldlr −/− mice 32 .
There may be other mechanisms of Hif1a stabilization. Notably, the oxidative stress associated with an energy crisis may directly stabilize Hif1a and promote Vegfa secretion from Vldlr −/− photoreceptors 4, 33, 34 , potentially contributing to vascular lesion formation. Although macrophages are often implicated in the etiology of AMD, we did not find evidence for their association with the onset of nascent RAP-like lesion development in retinas from Vldlr −/− mice; we also observed that macrophages surrounded mature but not immature vascular lesions (Supplementary Fig. 10) . To translate these findings to human disease, we measured vitreous VEGFA levels in human subjects with AMD, who had choroidal neovascularlization (CNV) or RAP. These levels were higher than those in control subjects with a macular hole (i.e., without neovascularization) (Fig. 4j) . These findings imply that an insufficiency of lipid and glucose fuels in the retina, in part through a reduction in the Krebs cycle metabolite α-KG, can drive aberrant angiogenesis in the normally avascular photoreceptor layer. In the retina, the ability to use both lipids and glucose as fuel might be beneficial in periods of high fuel need or fuel deprivation. Fasting liberates fatty acid from adipose tissue, which is used by high-energyconsuming organs capable of fatty acid β-oxidation, such as the heart and perhaps the retina. Indeed, disorders of fatty acid β-oxidation are associated with retinopathy 35 . Moreover, Ppara agonists that increase fatty acid β-oxidation have been used successfully to prevent diabetic proliferative retinopathy 36 , and further exploration of the role of Ppara in metabolic signaling in neovascular eye disease is warranted. Overall, our findings suggest that lipids are an energy substrate in the retina, challenging the current dogma that glucose is the only fuel for photoreceptors.
Tissues that use lipid as fuel curb glucose uptake during starvation 1, 37 ; thus, the capacity to sense nutrient availability and adapt fuel uptake accordingly might improve metabolic efficiency. GPCRs are known membrane sensors for the availability of amino acids, glucose and lipids 38 . Here we show that Ffar1 is a metabolic sensor of fatty acid availability, which controls glucose entry into the retina. We speculate that long-term suppression of glucose entry by Ffar1 in photoreceptors (perhaps secondary to increased levels of circulating lipids) might contribute to age-related mitochondrial dysfunction in AMD or MacTel. The retinal effects of Ffar1 agonists, which are currently being considered for the treatment of type 2 diabetes, should be carefully monitored, particularly in older individuals who are at an increased risk for AMD.
Dysregulated mitochondrial metabolism might contribute to pathological angiogenesis in other diseases, such as cancer. Viewed in this context, the Warburg effect-in which suppressed mitochondrial oxidative phosphorylation leads to lower levels of α-KG-promotes angiogenesis at the cost of efficient ATP production 31, 39, 40 . Decreased levels of α-KG would decrease PHD activity, leading to Hif1a stabilization, which would drive tumor angiogenesis. Our findings suggest the importance of mitochondrial fuel starvation as a driver of angiogenesis, matching energy demands with vascular supply. With a decline in mitochondrial function with age, this process may contribute to pathological angiogenesis in diseases associated with aging retina.
In summary, we show that lipid uptake and lipid β-oxidation are curtailed in Vldlr −/− retinas. Increased levels of circulating fatty acids can activate Ffar1, leading to decreased retinal glucose uptake and decreased levels of the Krebs cycle intermediate α-KG. Consequently, Hif1a is stabilized and Vegfa is secreted by Vldlr −/− photoreceptors, giving rise to pathologic RAP-like neovessels. This study highlights three new mechanistic insights into retinal physiology and neovascular AMD-RAP: (i) lipid β-oxidation is an energy source for the retina; (ii) Ffar1 is an important nutrient sensor of circulating lipids that controls retinal glucose entry to match mitochondrial metabolism with the available fuel substrates; and (iii) nutrient scarcity is a driver of pathological angiogenesis in the retina. These insights may thus contribute to the discovery of new treatments for retinal disease.
METHoDs
Methods and any associated references are available in the online version of the paper. Vldlr-knockout mice (Vldlr −/− ; Jackson Lab stock: 002529) were crossed with wild-type C57BL/6 mice to obtain heterozygous breeders for littermatecontrolled experiments. Vldlr −/− mice were also crossed with Ffar1-knockout (Ffar1 −/− ) mice 1 to ultimately obtain Vldlr −/− Ffar1 −/+ heterozygous breeders and double-knockout mice (Vldlr −/− Ffar1 −/− ). Pups weighing <5 g or >7 g at postnatal day (P)16 were excluded 42 . Littermate Vldlr −/− pups were treated from P8 to P15 with WY164363 (50 mg per kg body weight (mg/kg) once daily; by intraperitoneal injection (i.p.); Sigma), GW9508 (14 µM, once daily; i.p.; Cayman), TAK-875 (15 mg/kg twice daily; by gavage; Selleckchem), medium-chain triglyceride oil (MCT; 20 µl once daily; by gavage; Nestle) or the corresponding vehicle and were sacrificed at P16 to quantify retinal vascular lesions. Mouse pups of both genders were used.
Accession codes. Gene Expression

Quantification of vascular lesions.
For quantification of outer retina vascular lesions, which are reminiscent of retinal angiomatous proliferation (RAP) or macular telangiectasia (MacTel), mice were euthanized with a mixture of xylazine and ketamine. Eyes were enucleated and fixed in 4% paraformaldehyde for 1 h at room temperature. Retinas were dissected, all hyaloid vessels were carefully removed, and the retinas were stained overnight at room temperature with fluoresceinated isolectin B 4 (lectin) (Alexa Fluor 594 -I21413, Molecular Probes) in 1 mM CaCl 2 in PBS. Lectin-stained retinas were whole-mounted onto Superfrost/Plus microscope slides (Fisher Scientific) with the photoreceptor side up and embedded in SlowFade Antifade reagent (Invitrogen). For quantification of retinal lesions, 20 images of each whole-mounted retina were obtained at 10× magnification on a Zeiss AxioObserver.Z1 microscope and merged to form one image using AxioVision 4.6.3.0 software. Vascular lesion counts were analyzed using the SWIFT_MACTEL method, an adaptation of the method used to measure neovascularization (SWIFT_NV) 43 in the oxygen-induced retinopathy model.
SWIFT_MACTEL.
We created a set of macros that was developed to run on the ImageJ platform (NIH; http://imagej.nih.gov/ij/). In brief, SWIFT_MACTEL isolates the red channel from a lectin-stained retinal whole mount, divides the image into four quadrants and removes background fluorescence to allow for the neovascularization (NV) structures to stand out clearly against the background fluorescence of normal vessels. Using a slide bar to either increase or decrease a particular quadrant's fluorescence threshold, the SWIFT_MACTEL user designates a threshold that marks NV structures but not normal vessels in each quadrant. After setting the appropriate threshold, artifacts like cellular debris or hyperfluorescent retinal edges can be manually removed and excluded from quantification. SWIFT_MACTEL then analyzes all pixels in the image that lie above the chosen intensity threshold and that are part of an object that has a minimum size of 100 pixels. By setting this cut-off in object size, small artifacts like vessel branch points are automatically removed. After measuring all four quadrants, SWIFT_MACTEL creates a composite from all four NV quadrants and calculates the total NV pixel number. Results from the SWIFT_NV method have been found to correlate well with results from the established hand-measurementbased protocols (R 2 = 0.9372) and show robust intra-individual (R 2 = 0.9376) and inter-individual (R 2 = 0.9424) reproducibility 42 . The n number is the number of eyes quantified.
Scanning electron microscopy and three-dimensional (3D) retinal reconstruction. Tissue was processed for serial block-face scanning electron microscopy (SEM) using an adapted version of a protocol established by Deerinck et al. 2010 (ref. 44) . Whole eyes were isolated and fixed in Karnovsky's fixative. The cornea and lens were removed and the tissue was further fixed in tannic acid overnight. Heavy-metal infiltration was then undertaken; tissue was incubated in 1.5% potassium ferrocyanide and 0.5% osmium tetroxide in cacodylate buffer, followed by thiocarbohydrazide treatment and a second exposure to 1% osmium. Walton's lead aspartate exposure was not carried out, so preparation of the tissue was finished with a 1% uranyl acetate incubation followed by dehydration to propylene oxide, and the tissue was embedded in Durcupan ACM resin. The tissue was serially sectioned and imaged using the Gatan 3VIEW serial block-face imaging system (Gatan, Abingdon, UK) fitted to a Zeiss Sigma variable pressure-field emission scanning electron microscope (Zeiss, Cambridge, UK). Data was collected and used in Amira Software (FEI, Oregon, USA) in order to reconstruct the 3D images. Using the same software, photoreceptor mitochondrial volume was estimated for WT mice, around the lesion in Vldlr −/− mice, and away from the lesion in Vldlr −/− mice. ATP measurements. ATP was measured using a kit, as per the instruction manual (Molecular Probes, A22066). Briefly, a standard reaction solution was made from the following components: dH 2 O, 20× Reaction Buffer, DTT (0.1 M), d-luciferin (10 mM), and firefly luciferase stock solution (5 mg/ml). Low-concentration ATP standard solutions were prepared by diluting ATP solution (5 mM) in dH 2 O. A standard curve was generated by subtracting the background luminescence of the standard reaction solution from luminescence readings for a series of dilute ATP standard solutions. Luminescence measurements were taken for ATP-containing samples, and the amount of ATP in experimental samples was calculated from the standard curve.
Oxygen-consumption and extracellular-acidification rates. All oxygenconsumption rates (OCRs) were measured using a Seahorse XF e 96 Flux Analyzer. Whole retinas were isolated and 1-mm punch biopsies were loaded into a 96-well plate. Retinal punches were incubated in assay medium (Dulbecco's modified Eagle's medium (DMEM) 5030 supplemented with 12 mM glucose, 10 mM HEPES and 26 mM NaHCO 3 ) to measure OCRs and extracellular acidification rates (ECARs). Photoreceptor (661W) cells were incubated in assay medium (DMEM 5030, 12 mM glucose, 10 mM HEPES) 1 hour before taking measurements. Fatty acid oxidation rates were determined by treating tissues or cells with etomoxir (40 µM; Sigma) 40 min before analysis and then providing BSA (control) or a BSA-palmitate conjugate (Seahorse). Glucose oxidation rates were measured after injection of 2-deoxyglucose (2-DG, 100 mM; Sigma) or a medium control during data acquisition.
To determine the amount of proton uncoupling (OCR independent of ATP production), oligomycin (2 µM), an inhibitor of ATP synthase, was injected. To determine the maximal fatty acid or glucose oxidative capacity, the nonmitochondrial respiration rate (measured after injection of 2 µM rotenone and 2 µM antimycin A (RAA)) was subtracted from the oxygenconsumption rate measured after injection of 0.5 µM carbonyl cyanidep-trifluoromethoxyphenylhydrazone (FCCP).
Glucose and lactate measurements. Whole retinas and photoreceptors (661W) were incubated in assay medium (DMEM 5030, 12 mM glucose, 10 mM HEPES) for 6 and 48 h, respectively. Medium was collected and spun briefly (13,000g) to remove cellular debris, and glucose and lactate levels measured using a Yellow Springs Instrument (YSI) 2950; results were compared to control medium that was not exposed to tissue or cells. To determine the conversion of glucose to lactate (the glycolytic rate), the amount of lactate produced was divided by the amount of glucose taken up.
Retinal lipid uptake. We compared retinal uptake of long-chain fatty acid in wild-type and Vldlr −/− mice gavaged with 0.1 mg of 4,4-difluoro-5,7dimethyl-4-bora-3a, 4a-diaza-s-indacene-3-hexadecanoic acid (BODIPY FL C16; Molecular Probes). Mice were euthanized 2 h later, and the eyes were enucleated, embedded in OCT and cryosectioned (10 µm) for immediate imaging by fluorescence microscopy. Retinal fatty acid uptake was quantitated using a 14 C-labeled 2-bromopalmitate tracer injected twice daily (i.p.; 0.5 µCi per dose) from P9 to P12; the total administered radioactivity was normalized for mouse body weight. Retinas were then dissected and homogenized in Ultima Gold liquid scintillation cocktail (PerkinElmer) and beta-counted ( 14 C disintegration per minute or DPM) using a Tri-Carb 2900TR instrument (PerkinElmer), correcting for background scintillation.
